Association of Seven Polymorphisms of the D2 Dopamine Receptor Gene with Brain Receptor-Binding Characteristics

被引:0
|
作者
Terry Ritchie
Ernest P. Noble
机构
[1] University of California,Department of Psychiatry and Biobehavioral Sciences
来源
Neurochemical Research | 2003年 / 28卷
关键词
D2 dopamine receptor gene; D2 dopamine receptor binding; polymorphism; alcoholism; linkage disequilibrium; allelic association;
D O I
暂无
中图分类号
学科分类号
摘要
Association of alleles at the Taql A, Taql B, intron 6, Taql D, exon 7, exon 8, and promoter-141C sites of the D2 dopamine receptor gene with D2 dopamine receptor binding characteristics in the caudate nucleus of Caucasian alcoholic and nonalcoholic subjects was determined. For the Taql D, exon 7, exon 8, and promoter-141C sites there were no significant allelic differences in Bmax (number of binding sites) or Kd (binding affinity) of the D2 dopamine receptors. However, subjects having the minor alleles at the Taql A, Taql B, and intron 6 sites had significantly lower Bmax than subjects not having them. None of these three polymorphisms had any significant effect on Kd. Highly significant linkage disequilibria were observed among the Taql A, Taql B, and intron 6 polymorphic sites, but linkage disequilibria between these three sites and each of the Taql D, exon 7, exon 8, and promoter-141C sites were of lesser or of no significance. Taken together, these findings suggest that the Taql A, Taql B, and intron 6 polymorphisms, but not the Taql D, exon 7, exon 8, and promoter-141C polymorphisms, are in linkage disequilibrium with a functional allelic variant that affects D2 dopamine receptor expression.
引用
收藏
页码:73 / 82
页数:9
相关论文
共 50 条
  • [21] DOPAMINE D2 AND MUSCARINIC RECEPTOR-BINDING CHARACTERISTICS IN RAT-BRAIN AFTER WITHDRAWAL OF SUBCHRONIC FLUPHENAZINE AND SULPIRIDE TREATMENT
    HIETALA, J
    SYVALAHTI, E
    ROYTTA, M
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1989, 13 (1-2): : 247 - 258
  • [22] Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD
    Wang, J
    Liu, ZL
    Chen, B
    NEUROLOGY, 2001, 56 (12) : 1757 - 1759
  • [23] Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia
    Hori, H
    Ohmori, O
    Shinkai, T
    Kojima, H
    Nakamura, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2001, 105 (08): : 774 - 778
  • [24] Association of Dopamine D2 Receptor Gene Polymorphisms with Reproduction Traits in Domestic Pigeons (Columba livia)
    Yin, Zhaozheng
    Dong, Xinyang
    Ma, Youzhi
    Dong, Dingjuan
    JOURNAL OF POULTRY SCIENCE, 2017, 54 (01): : 13 - 17
  • [25] Association studies of polymorphisms in the promoter region of the dopamine D4 receptor and the D2 receptor.
    Fitzpatrick, E
    Spurlock, G
    Coleman, S
    Owen, MJ
    Buckland, PR
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2000, 96 (04): : 530 - 530
  • [26] PURIFICATION OF BRAIN D2 DOPAMINE RECEPTOR
    WILLIAMSON, RA
    WORRALL, S
    CHAZOT, PL
    STRANGE, PG
    EMBO JOURNAL, 1988, 7 (13): : 4129 - 4133
  • [27] Association of a dopamine D2 receptor gene polymorphism with Parkinson disease
    Ezquerra, M
    Campdelacreu, J
    Munnoz, E
    Marti, M
    Valldoriola, F
    Tolosa, E
    MOVEMENT DISORDERS, 2004, 19 : S349 - S349
  • [28] Dopamine D2 receptor gene polymorphisms and externalizing behaviors in children and adolescents
    Della Torre, Osmar Henrique
    Paes, Lucia Arisaka
    Henriques, Taciane Barbosa
    de Mello, Maricilda Palandi
    Rubello Valler Celeri, Eloisa Helena
    Dalgalarrondo, Paulo
    Guerra-Junior, Gil
    dos Santos-Junior, Amilton
    BMC MEDICAL GENETICS, 2018, 19
  • [29] ALLELIC ASSOCIATION OF THE D2 DOPAMINE-RECEPTOR GENE WITH OBESITY
    NOBLE, EP
    NOBLE, RE
    RITCHIE, T
    GRANDY, DK
    SPARKES, RS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1993, 53 (03) : 117 - 117
  • [30] Dopamine D2 receptor gene polymorphisms and tardive dyskinesia in schizophrenia patients
    Lee, H. J.
    Kang, S. G.
    Cho, C. H.
    Cho, J. E.
    Kim, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S210 - S211